HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronica Francardo Selected Research

Muscarinic M4 Receptor

1/2016M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
11/2015M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronica Francardo Research Topics

Disease

16Parkinson Disease (Parkinson's Disease)
01/2019 - 12/2010
12Dyskinesias (Dyskinesia)
01/2018 - 12/2010
2Parkinsonian Disorders (Parkinsonism)
01/2019 - 07/2014
1Infections
04/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Huntington Disease (Huntington's Disease)
01/2019
1Substance-Related Disorders (Drug Abuse)
02/2016
1Dementia (Dementias)
11/2015
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2015

Drug/Important Bio-Agent (IBA)

12Levodopa (L Dopa)FDA LinkGeneric
01/2018 - 12/2010
5Oxidopamine (6 Hydroxydopamine)IBA
01/2019 - 06/2011
4Dopamine (Intropin)FDA LinkGeneric
01/2018 - 12/2010
3Sigma-1 ReceptorIBA
01/2019 - 07/2014
2Pharmaceutical PreparationsIBA
11/2017 - 02/2016
2Muscarinic M4 ReceptorIBA
01/2016 - 11/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 08/2011
1Nasal SpraysIBA
04/2022
1PlasticsIBA
01/2020
1pridopidineIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
11/2015
1Proteins (Proteins, Gene)FDA Link
07/2014
1Biological ProductsIBA
01/2012
1Nerve Growth Factors (Neurotrophins)IBA
01/2012
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2012
1NestinIBA
08/2011
1RNA (Ribonucleic Acid)IBA
08/2011
1ras-GRF1 (ras GRF1)IBA
12/2010
1Therapeutic UsesIBA
12/2010

Therapy/Procedure

4Therapeutics
01/2018 - 12/2010
3Drug Therapy (Chemotherapy)
03/2014 - 08/2011
1Oral Administration
01/2018